Cargando…
Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study
Antibiotic-loaded bone cement is the most widely used approach for the treatment of biofilm-induced septic sequelae in orthopedic surgery. Dalbavancin is a lipoglycopeptide that acts against Gram-positive bacteria and has a long half-life, so we aimed to assess whether it could be a new alternative...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598415/ https://www.ncbi.nlm.nih.gov/pubmed/36289958 http://dx.doi.org/10.3390/antibiotics11101300 |
_version_ | 1784816328371077120 |
---|---|
author | Sánchez-Somolinos, Mar Díaz-Navarro, Marta Benjumea, Antonio Tormo, Marta Matas, José Vaquero, Javier Muñoz, Patricia Sanz-Ruíz, Pablo Guembe, María |
author_facet | Sánchez-Somolinos, Mar Díaz-Navarro, Marta Benjumea, Antonio Tormo, Marta Matas, José Vaquero, Javier Muñoz, Patricia Sanz-Ruíz, Pablo Guembe, María |
author_sort | Sánchez-Somolinos, Mar |
collection | PubMed |
description | Antibiotic-loaded bone cement is the most widely used approach for the treatment of biofilm-induced septic sequelae in orthopedic surgery. Dalbavancin is a lipoglycopeptide that acts against Gram-positive bacteria and has a long half-life, so we aimed to assess whether it could be a new alternative drug in antibiotic-loaded bone cement for the treatment of periprosthetic joint infections. We assessed the elution capacity of dalbavancin and compared it with that of vancomycin in bone cement. Palacos(®)R (Heraeus Medical GmbH, Wehrheim, Germany) bone cement was manually mixed with each of the antibiotics studied at 2.5% and 5%. Three cylinders were obtained from each of the mixtures; these were weighed and incubated in 5 mL phosphate-buffered saline at 37°C under shaking for 1 h, 2 h, 4 h, 8 h, 24 h, 48 h, 168 h, and 336 h. PBS was replenished at each time point. The samples were analyzed using high-performance liquid chromatography (vancomycin) and mass cytometry (dalbavancin). Elution was higher than the minimum inhibitory concentration (MIC)90 for both antibiotics after 14 days of study. The release of vancomycin at 14 days was higher than of dalbavancin at each concentration tested (p = 0.05, both). However, the cumulative release of 5% dalbavancin was similar to that of 2.5% vancomycin (p = 0.513). The elution capacity of dalbavancin reached a cumulative concentration similar to that of vancomycin. Moreover, considering that the MIC90 of dalbavancin is one third that of vancomycin (0.06 mg/L and 2 mg/L, respectively) and given the long half-life of dalbavancin, it may be a new alternative for the treatment of biofilm-related periprosthetic infections when loaded in bone cement. |
format | Online Article Text |
id | pubmed-9598415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95984152022-10-27 Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study Sánchez-Somolinos, Mar Díaz-Navarro, Marta Benjumea, Antonio Tormo, Marta Matas, José Vaquero, Javier Muñoz, Patricia Sanz-Ruíz, Pablo Guembe, María Antibiotics (Basel) Article Antibiotic-loaded bone cement is the most widely used approach for the treatment of biofilm-induced septic sequelae in orthopedic surgery. Dalbavancin is a lipoglycopeptide that acts against Gram-positive bacteria and has a long half-life, so we aimed to assess whether it could be a new alternative drug in antibiotic-loaded bone cement for the treatment of periprosthetic joint infections. We assessed the elution capacity of dalbavancin and compared it with that of vancomycin in bone cement. Palacos(®)R (Heraeus Medical GmbH, Wehrheim, Germany) bone cement was manually mixed with each of the antibiotics studied at 2.5% and 5%. Three cylinders were obtained from each of the mixtures; these were weighed and incubated in 5 mL phosphate-buffered saline at 37°C under shaking for 1 h, 2 h, 4 h, 8 h, 24 h, 48 h, 168 h, and 336 h. PBS was replenished at each time point. The samples were analyzed using high-performance liquid chromatography (vancomycin) and mass cytometry (dalbavancin). Elution was higher than the minimum inhibitory concentration (MIC)90 for both antibiotics after 14 days of study. The release of vancomycin at 14 days was higher than of dalbavancin at each concentration tested (p = 0.05, both). However, the cumulative release of 5% dalbavancin was similar to that of 2.5% vancomycin (p = 0.513). The elution capacity of dalbavancin reached a cumulative concentration similar to that of vancomycin. Moreover, considering that the MIC90 of dalbavancin is one third that of vancomycin (0.06 mg/L and 2 mg/L, respectively) and given the long half-life of dalbavancin, it may be a new alternative for the treatment of biofilm-related periprosthetic infections when loaded in bone cement. MDPI 2022-09-23 /pmc/articles/PMC9598415/ /pubmed/36289958 http://dx.doi.org/10.3390/antibiotics11101300 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sánchez-Somolinos, Mar Díaz-Navarro, Marta Benjumea, Antonio Tormo, Marta Matas, José Vaquero, Javier Muñoz, Patricia Sanz-Ruíz, Pablo Guembe, María Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study |
title | Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study |
title_full | Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study |
title_fullStr | Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study |
title_full_unstemmed | Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study |
title_short | Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study |
title_sort | determination of the elution capacity of dalbavancin in bone cements: new alternative for the treatment of biofilm-related peri-prosthetic joint infections based on an in vitro study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598415/ https://www.ncbi.nlm.nih.gov/pubmed/36289958 http://dx.doi.org/10.3390/antibiotics11101300 |
work_keys_str_mv | AT sanchezsomolinosmar determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT diaznavarromarta determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT benjumeaantonio determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT tormomarta determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT matasjose determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT vaquerojavier determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT munozpatricia determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT sanzruizpablo determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy AT guembemaria determinationoftheelutioncapacityofdalbavancininbonecementsnewalternativeforthetreatmentofbiofilmrelatedperiprostheticjointinfectionsbasedonaninvitrostudy |